(Q41365624)

29 September 2017

Glycoinositolphospholipids of Leishmania major inhibit nitric oxide synthesis and reduce leishmanicidal activity in murine macrophages (English)

1 reference

29 September 2017

Leishmania major

1 reference

Proudfoot L

1

1 reference

29 September 2017

O'Donnell CA

series ordinal

2

1 reference

29 September 2017

Liew FY

series ordinal

3

1 reference

29 September 2017

language of work or name

English

0 references

publication date

1 March 1995

1 reference

European Journal of Immunology

29 September 2017

1 reference

29 September 2017

25

1 reference

29 September 2017

3

1 reference

29 September 2017

745-750

1 reference

Cytokines in leishmaniasis: a complex network of stimulatory and inhibitory interactions.

29 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250318

Characterization of glycoinositol phospholipids in the amastigote stage of the protozoan parasite Leishmania major.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250318

The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250318

Inhibitory effects on protein kinase C activity by lipophosphoglycan fragments and glycosylphosphatidylinositol antigens of the protozoan parasite Leishmania

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250318

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250318

7 January 2021

Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250318

7 January 2021

Nitric oxide: a cytotoxic activated macrophage effector molecule

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250318

7 January 2021

Nitric oxide as a secretory product of mammalian cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250318

7 January 2021

Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250318

7 January 2021

An L-arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250318

7 January 2021

Induction of nitric oxide synthase in rat peritoneal neutrophils and its inhibition by dexamethasone

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250318

7 January 2021

Killing of Leishmania parasites in activated murine macrophages is based on an L-arginine-dependent process that produces nitrogen derivatives

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250318

7 January 2021

Role of inorganic nitrogen oxides and tumor necrosis factor alpha in killing Leishmania donovani amastigotes in gamma interferon-lipopolysaccharide-activated macrophages from Lshs and Lshr congenic mouse strains

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250318

7 January 2021

Leishmania major-specific CD8+ T cells are inducers and targets of nitric oxide produced by parasitized macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250318

7 January 2021

The glycoinositolphospholipid profiles of two Leishmania major strains that differ in lipophosphoglycan expression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250318

7 January 2021

The lipophosphoglycan of Leishmania

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250318

7 January 2021

Lipophosphoglycan of Leishmania major that vaccinates against cutaneous leishmaniasis contains an alkylglycerophosphoinositol lipid anchor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250318

7 January 2021

Reevaluation of the phenol-sulfuric acid reaction for the estimation of hexoses and pentoses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250318

7 January 2021

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250318

7 January 2021

Model for membrane movements in the neural growth cone.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250318

7 January 2021

A modified colorimetric assay of macrophage activation for intracellular cytotoxicity against Leishmania parasites

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250318

7 January 2021

Pre-exposure of murine macrophages to lipopolysaccharide inhibits the induction of nitric oxide synthase and reduces leishmanicidal activity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250318

7 January 2021

Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250318

7 January 2021

Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250318

7 January 2021

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250318

7 January 2021

A possible novel pathway of regulation by murine T helper type-2 (Th2) cells of a Th1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250318

7 January 2021

The role of protein kinase C in the induction of nitric oxide synthesis by murine macrophages.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250318

7 January 2021

Identifiers

DOI

10.1002/EJI.1830250318

1 reference

29 September 2017

1 reference